Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision-making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, drug response prediction, and development of companion diagnostics.
We are a CRO specialising in the analysis of proteins and their associated PTM’s via advanced Mass Spectrometry. By using proprietary methodologies, we can detect up to 8,000 proteins per sample in Discovery mode and can offer multiplexed assays of up to 100 proteins/sample in a GCLP accredited Targeted assay.
With their proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.
With over 15 years of experience in genetic and epigenetic clinical research, EpigenDx offers high quality products and laboratory services focused on DNA methylation analysis, gene expression profiling, and mutation analysis. Our scientific teams carefully evaluate each project and establish analysis procedures using best fit technologies, including NGS, Pyrosequencing, RT-PCR, digital PCR, and GeneChip Microarray. Our popular services include Line-1 global methylation tests and Foxp3-TSDR analysis for epigenetic immunotherapy. Our GLP compliant and CLIA certified services make us the perfect partner during pre-clinical research and diagnostic test development.
Bionano transform the way the world sees the genome through Optical Genome Mapping solutions, diagnostic services, and software. Bionano Saphyr® system offers an extremely long-read technology, providing unmatched sensitivity to detect any type of structural variation (SV) and copy number variation (CNV), unbiased and genome wide, at low cost.
Different from sequencing and by leveraging direct visualization of whole-genome DNA molecules, Bionano workflow can resolve complex repetitive regions, and Bionano’s high coverage depth can identify low allele fraction event.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com
Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology that can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies. For further information on Lunaphore and its products, please visit www.lunaphore.com
Malvern Panalytical brand, Concept Life Sciences, is a knowledge and science-led contract research organisation. We are problem-solvers and trusted partners with a proven track record in life sciences, laboratory based analytical testing and mechanistic toxicology. We deliver a comprehensive platform of integrated solutions built on expert knowledge, collaboration, flexibility and extensive in-house resources.
Sanyou Biopharmaceuticals is a CRO company featuring phage display antibody libraries of trillion capacity and offering integrated solutions for innovative antibody drugs that include antibody discovery, efficacy validations and CMC. Currently, the company has 240+ employees, R&D laboratories of 11000 m2 and 300+ clients and partners all around the world.
Standard BioTools is committed to empowering the cancer immunotherapy community with research tools to interrogate the tumor microenvironment with unprecedented resolution. Whether you seek to target new biomarkers or to optimize the effectiveness of checkpoint inhibitors, CAR T cells or cancer vaccines, Standard BioTools can help you reach your next research breakthrough. Engage with us at www.standardbiotools.com
Cellecta, Inc., founded in 2006, is a trusted provider of functional genomic products and services for loss-of-function and gain-of-function phenotypic screening, cell barcoding as well as gene expression and T-cell and B-cell receptor profiling. This includes design and manufacture of CRISPR and RNAi libraries, lentiviral constructs and cell engineering services as well as NGS profiling assays and spatial transcriptomic services for drug target and biomarker discovery and other applications. For more information visit cellecta.com
Vizgen is developing the next generation of genomic profiling tools that enable researchers to gain new insight into the biological systems that underlie human health and disease with spatial context. The company's MERSCOPE platform enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and unrivalled detection efficiency at subcellular resolution. MERSCOPE provides transformative insight into a wide range of tissue-scale basic research and translational medicine. For more information, go to www.vizgen.com.
Bio-Techne® unites some of the most referenced brands in Life Sciences: R&D Systems®, Novus Biologicals®, Tocris®, ProteinSimple®, Advanced Cell Diagnostics® and Exosome Diagnostics®. Our family of brands collaborate to provide over 350,000 products for Life Science research. We have over 350,000 journal citations, showing that our combined experience is trusted by researchers. We are passionate about scientific discovery, which drives us to manufacture high-quality reagents and award-winning tools for the Life Science and Clinical Diagnostic markets. We understand our customers and we really care about their research. We want to make sure that their experiments are successful by providing reliable high-performance innovative solutions for scientific discovery.
Arima Genomics is a biotechnology company that advances the life sciences through the power of 3D genomes. We develop innovative solutions that drive discovery in genomics and improve human health. Our advanced Hi-C technology enables a range of products and applications by providing unparalleled access to the sequence and structure of any genome.
TransCure bioServices (TCS) provides predictive in vivo pharmacology expertise for drug pre-clinical candidate selection in the fields of infectious, cancer (IO, PDX), inflammation, vaccine and immune disease areas. We are the only preclinical CRO providing commercially HIV, immuno-oncology (IO) therapy, PDX, IBD, vaccine and autoimmune mouse models with a fully functional reconstituted HUMAN IMMUNE SYSTEM (hu-mouse models). We co-design study protocols/experiments performing the ordered studies and providing comprehensive data collection, data analysis and reports.
Veracyte is a pioneering, global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions. Our growing menu of advanced diagnostic tests help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment. Veracyte offers customized multi-omics tools and expertise to our biopharmaceutical partners, helping them advance their therapeutic discovery, development and commercialization programs.
PreOmics – Setting the Standard for Protein Analysis
PreOmics empowers our clients in life sciences to establish biological knowledge through efficient, reliable solutions and workflows that set the standard for protein analysis.
We envisage a future with revolutionary proteomic discovery processes open for everyone.
At Biognosys, we believe that proteome insights unfold breakthrough discoveries that can dramatically improve human health. With our versatile portfolio of proprietary next-generation proteomics services, software, and kits, we provide a multi-dimensional view of protein expression, function, and structure in all sample types. Our patented technologies utilize high-resolution mass spectrometry, and through advanced data analytics, we translate data into actionable insights for R&D and clinical research.
Cureline, Inc. is a global contract research organization (CRO) and a commercial biobank supporting preclinical research in oncology, hematology, immune-oncology and various other therapeutic areas (Cardio-vascular, metabolic, neuro-degenerative, infectious and inherited conditions) to the pharmaceutical, biotechnology, and medical device industries worldwide since 2003.
Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications, and expertise, enabling customers to gain the insights they seek. Agilent is providing the entire workflow of target enrichment for different NGS applications such as cancer, infectious and rare diseases. including sample quality control (QC), next-generation sequencing (NGS) library prep and target enrichment, microarrays, CRISPR, PCR/qPCR, bioreagents, and data analysis solutions from interpretation reporting. Furthermore, with the extensive cancer diagnostic and pathology know-how of Agilent Dako, built on more than 50 years of experience, our business of antibodies & assay solutions has established lasting partnerships worldwide with partnering companies, ranging from large multinationals to smaller manufacturers and commercial laboratories specializing in the fields of in vitro diagnostics, biotechnology and pharmaceuticals. Besides the development of companion diagnostic for novel personalized therapy in cancer treatment, collaboration partners also benefit from the high level of familiarity of the Agilent Pathology-portfolio in routine diagnostic.
Canopy Biosciences(r), a Bruker company, empowers innovation by providing access to cutting-edge spatial biology and multi-omic tools so biomedical researchers can drive scientific discovery faster. We offer instruments and services for spatial proteomics and transcriptomics, gene expression profiling, and CLIA services for IHC, FISH and histopathology. Learn more by visiting CanopyBiosciences.com.
Quantabio is a leading provider of advanced DNA and RNA amplification reagents for the most demanding molecular testing applications in applied, translational, and life science research. Our team leverages decades of experience in developing pioneering amplification technologies to deliver cutting-edge products to researchers focused on critical cloning, PCR, qPCR, and Next-Generation Sequencing (NGS) applications.
Based in Beverly, Massachusetts, Quantabio offers a growing portfolio of products through its international sales operations, as well as a global network of distributors and commercial service providers.
PeproTech is a business unit within the Thermo Fisher Scientific Biosciences Division, specializing in manufacturing high quality cytokine products and providing exceptional service to the global life science and cell therapy markets. Our products include Recombinant Human, Murine and Rat Cytokines, Animal-Free Recombinant Cytokines, GMP Cytokines, Antibodies and ELISA Kits.
Novogene utilises scientific excellence, a commitment to customer service and unsurpassed data quality to help our clients realise their research goals in the rapidly evolving world of genomics. With over 2,000 employees, multiple locations around the world, 37 NGS related patents, and over 670 publications in top tier journal such as Nature and Science, the company has rapidly become a world-leader in NGS services. In this conference, we will exhibit the latest genome sequencing solutions.
BioIVT is a leading global provider of high-quality biological specimens and value-added services. We specialize in control and disease state samples including human and animal tissues, cell products, blood, and other biofluids. Our unmatched portfolio of clinical specimens supports precision medicine by coupling comprehensive clinical data with donor samples. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®
Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities. Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMab™ Mouse), and in vivo/in vitro preclinical validation studies. Together, we discover innovative medicines for a better, healthier world.
Abzena is a leading partner research organization that offers integrated discovery, development and cGMP manufacture services for biologics and bioconjugates. Abzena provides the most complete set of solutions in integrated early discovery to mid-phase biotherapeutic and bioconjugation drug development and manufacturing in the biopharmaceutical industry. The company maintains resources around the world, with facilities in the US and UK.
Talem Therapeutics is a biotherapeutic company and a wholly owned subsidiary of ImmunoPrecise Antibodies (IPA) that leverages IPA’s antibody discovery and development expertise combined with AI/bioinformatics to generate valuable assets (best-in-class / first-in-class) for out-licensing and co-development. Talem's experts focus on next generation antibodies from target validation through IND-Readiness (indication agnostic).
Established in 2004, LARVOL combines the best of artificial and human intelligence to deliver expertly curated and personalized data solutions to medical affairs, competitive intelligence, commercial, and R&D teams within the pharmaceutical and biotech industry.
